Description
This webinar explores premature ovarian failure, focusing on its etiology, diagnosis, and clinical implications. It will review hormonal evaluation, imaging findings, and differential diagnoses. Management strategies including hormone replacement therapy and fertility preservation options will be discussed. The session will also address long-term health risks such as osteoporosis and cardiovascular disease. Practical counseling approaches for affected patients will be highlighted to support holistic care.
Summary Listen
- Premature ovarian failure (POF), affecting 1% of women under 40, isn't rare, accounting for 10-28% of primary and 4-18% of secondary amenorrhea cases. Diagnosis involves investigating women under 40 with amenorrhea or oligomenorrhea and estrogen deficiency signs, with elevated follicle-stimulating hormone (FSH) levels (>25 mIU/mL) as a key indicator.
- POF poses risks like neurological diseases, psychosexual dysfunction, mood disorders, osteoporosis, ischemic heart disease, infertility, and premature death, exceeding risks in regular menopause. Its etiology is complex, involving genetic factors, autoimmune diseases, infections, iatrogenic causes, and lifestyle factors like smoking.
- Genetic factors implicate gonadotropin receptor dysfunction, specifically FSHR gene mutations on 2p21, affecting follicle development. G protein, a second messenger system linked to FSHR and LSH receptor, can also be involved, with defects potentially leading to pseudo-hypoparathyroidism and hypothyroidism.
- Explainable causes include chromosomal abnormalities like Turner syndrome and 17-alpha hydroxylase deficiency. Autoimmune mechanisms, present in up to 30% of cases, involve anti-ovarian antibodies and lymphocytic oophoritis, often associated with thyroid diseases, mumps, and Addison's disease.
- Infections, including mumps, tuberculosis, varicella, cytomegalovirus, malaria, and shigella, are linked to POF. While tuberculosis can cause amenorrhea due to endometrial destruction, it doesn't always involve ovarian failure. Smoking has a dose-related effect on menopause age, but passive smoking isn't associated with POF.
- Iatrogenic causes include radiation, chemotherapy (alkylating agents), and oophorectomy. Ovarian failure following hysterectomy may result from impaired vascular supply or loss of uterinocrine contributions to the ovary. Prophylactic oophorectomy and drugs like cyclophosphamide can also induce POF.
- Clinical features include vasomotor symptoms (hot flashes, night sweats), vaginal dryness, dyspareunia, urinary symptoms (frequency, urgency, incontinence), sexual dysfunction, sleep disturbances, headaches, depression, and anxiety. Urethral caruncles are more common in POF. Examination reveals loss of vaginal rugae, shortening of the vagina, and reduced vaginal secretions.
- Laboratory findings include FSH levels >40 mIU/mL and sex chromosome analysis. Consequences include short-term vasomotor symptoms and long-term risks of infertility, osteoporosis, and cardiovascular disease. Spontaneous resumption of cycles is rare, and pregnancy is uncommon without intervention.
- Management involves addressing pregnancy desires with ovulation induction or oocyte donation in IVF. Hormone replacement therapy (HRT) is the cornerstone for managing symptoms and preventing osteoporosis. HRT options include oral estrogens, creams, vaginal rings, transdermal patches, and subcutaneous implants, tailored to individual needs.
- HRT's long-term use is controversial due to potential breast cancer risks, but short-term use can mitigate symptoms like vaginal dryness and hot flashes. Lifestyle modifications like diet and exercise lack scientific proof for restoring menstruation. Stress reduction and increased sexual activity are suggested but unproven methods for period induction.
Sample Certificate
About the Speakers
.webp)
Dr. Pankaj Desai
Consultant Gynecologist, Janani Maternity Hospital, Vadodara, Gujarat
Comments
Comments
You must be logged in to leave a comment.